[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352223-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352223-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploring-the-role-of-long-noncoding-rnas-in-breast-cancer-progression-a-comprehensive-study-on-biomarkers-and-therapeutic-approaches","Exploring the Role of Long Noncoding RNAs in Breast Cancer Progression - A Comprehensive Study on Biomarkers and Therapeutic Approaches","","Breast cancer is a prevalent, heterogeneous disease marked by high mortality driven by treatment resistance, recurrence, and delayed detection. This study examines how long noncoding RNAs (LncRNAs) contribute to breast cancer development, focusing on their capacity to act as biomarkers and therapeutic targets. It reviews mechanistic links between aberrant LncRNA expression and signaling pathways, highlighting impacts on cell survival, invasion, and proliferation relevant to metastasis and prognosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploring-the-role-of-long-noncoding-rnas-in-breast-cancer-progression-a-comprehensive-study-on-biomarkers-and-therapeutic-approaches/352223/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploring-the-role-of-long-noncoding-rnas-in-breast-cancer-progression-a-comprehensive-study-on-biomarkers-and-therapeutic-approaches/352223.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on long noncoding RNAs in breast cancer?","Question",{"text":63,"@type":64},"The study focuses on how long noncoding RNAs contribute to breast cancer progression and how they can support biomarker discovery and therapeutic approaches.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do LncRNAs influence breast cancer progression according to the reviewed pathways?",{"text":68,"@type":64},"Aberrant LncRNA production affects breast cancer progression through interactions with pathways including EGF, TGF-β, NF-κB, PI3K/AKT, and p53.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are LncRNAs considered important for diagnosis, prognosis, and treatment development?",{"text":72,"@type":64},"The research highlights that LncRNAs can regulate multiple signaling pathways tied to cell survival, invasion, and proliferation, making them promising biomarkers and therapeutic targets.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352223,1790857478,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Cancer Medicine  \nREVIEW  OPEN ACCESS   \nExploring the Role of Long Noncoding RNAs in Breast Cancer Progression: A Comprehensive Study on Biomarkers and Therapeutic Approaches  \nRamin Moeini | Amin AhsanAlkhat | Saeid Ghorbian   \nDepartment of Biology, Ta.C., Islamic Azad University, Tabriz, Iran Correspondence: Saeid Ghorbian ([saeid.ghorbian@iau.ac.ir](saeid.ghorbian@iau.ac.ir))  \nReceived: 31 October 2024 | Revised: 22 March 2025 | Accepted: 23 November 2025  \nKeywords: breast cancer | LncRNA | metastasis | oncogene | prognosis | tumor suppressor  \nABSTRACT  \nBackground: Among the many forms of cancer that plague women all over the globe, breast cancer (BC) is one of the most prevalent kinds. BC is a multifaceted disease that can manifest in many ways depending on the individual.  \nAims: The identification of new biomarkers that may be used to diagnose and prognosis of the BC, as well as those that can aid in the creation of novel therapeutic approaches and the understanding of how to regulate multiple pathways in metastasis, may initiate the process of creating novel therapeutic interventions for cancer patients.  \nMaterials and Methods: According to data from recent studies, long noncoding RNAs (LncRNAs) contribute to the development of BC via several distinct biochemical mechanisms. Remembering that long LncRNAs are longer than 200 nucleotides and do not encode proteins is essential.  \nResults: Through its interaction with the EGF, TGF-β, NF-κB, PI3K/AKT, and p53 pathways, the abnormal production of LncRNA has a substantial impact on the progression of BC.  \nConclusions: This research investigates the biological properties of LncRNAs to ascertain their role in regulating cell signaling pathways and the subsequent changes in cell survival, invasion, and proliferation components that characterize BC.  \n1 | Introduction  \nBC is the dominant kind of cancer that affects women all over the world, with 2.26 million reported cases and 685,000 deaths worldwide in 2020 [1] . The high mortality rate associated with BC is attributed to treatment resistance, tumor recurrence, and delayed detection [2] . Despite advances in medical research and treatment strategies, BC remains a leading cause of cancerrelated deaths among women. This highlights the urgent need for innovative approaches to improve early diagnosis, prognostication, and therapeutic outcomes. BC is not a single disease but a heterogeneous group of disorders with diverse molecular characteristics and clinical behaviors [3]. On the basis of gene expression profiles, breast tumors are categorized into several subtypes,  \nincluding triple-negative breast cancer (TNBC), HER2-positive, and luminal A and B [3, 4] . For instance, because of the disease's aggressiveness and the scarcity of current treatments, TNBC poses significant therapeutic challenges. The result is a more dismal prognosis along with higher rates of invasion, metastasis, and recurrence compared to other BC subtypes. For this reason, it is crucial to comprehend the molecular pathways linked to TNBC pathogenesis and to identify novel treatment targets for these individuals [5]. This means that research is now being done on the potential use of LncRNAs as therapeutic targets for different malignancies and as biomarkers for diagnosis and prognosis [6] . According to recent genomic and bioinformatics investigations conducted across different species, eukaryotic genomes encode a diverse array of RNAs, including messenger  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2026; 15:e71438 1 of 23  \n[https://doi.org/10.1002/cam4.71438](https://doi.org/10.1002/cam4.71438)  \nRNAs (mRNAs) that code for proteins, short noncoding transcripts, and LncRNAs. In human cells, noncoding ","cbCaiaKZ6xLBprhT","https://ap.wps.com/l/cbCaiaKZ6xLBprhT","pdf",2053914,23,"English","# Introduction\n# Background and Rationale\n# Materials and Methods\n# Results and Pathway Mechanisms\n# Conclusions","[{\"question\":\"What is the main focus of the study on long noncoding RNAs in breast cancer?\",\"answer\":\"The study focuses on how long noncoding RNAs contribute to breast cancer progression and how they can support biomarker discovery and therapeutic approaches.\"},{\"question\":\"How do LncRNAs influence breast cancer progression according to the reviewed pathways?\",\"answer\":\"Aberrant LncRNA production affects breast cancer progression through interactions with pathways including EGF, TGF-β, NF-κB, PI3K/AKT, and p53.\"},{\"question\":\"Why are LncRNAs considered important for diagnosis, prognosis, and treatment development?\",\"answer\":\"The research highlights that LncRNAs can regulate multiple signaling pathways tied to cell survival, invasion, and proliferation, making them promising biomarkers and therapeutic targets.\"}]","Exploring the Role of Long Noncoding RNAs in Breast Cancer Progression - A Comprehensive Study on Biomarkers and Therapeutic Approaches | PDF",1790098386,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e30a53bef7f0b8206d5557a15a808790.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62fc1f619f05a984ca15a42df2359963.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c98262b58845f5f6bf75d8338ebf547.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44f158d964c90d8aea6697a939139b9c.webp",980,1287]